Questions raised for telemedical monitoring of diabetic foot ulcers

Questions raised for telemedical monitoring of diabetic foot ulcers

(HealthDay)—Telemedicine monitoring is not associated with any significant difference in amputation or healing, but may be linked to increased mortality for patients with diabetic foot ulcers, according to a study published online June 26 in Diabetes Care.

Benjamin S.B. Rasmussen, from the Odense University Hospital in Denmark, and colleagues compared telemedicine and standard outpatient monitoring in the care of patients with diabetic . One hundred ninety-three patients were randomly allocated to telemedical monitoring, which consisted of two consultations in the patient's home and one in the outpatient clinic; 181 patients were randomized to standardized care, which included three outpatient clinic visits.

The researchers observed no difference with respect to wound healing (hazard ratio [HR], 1.11; 95 percent confidence interval [CI], 0.87 to 1.42; P = 0.42) or amputation (HR, 0.87; 95 percent CI, 0.54 to 1.42; P = 0.59) for individuals monitored through telemedicine or standard care. The incidence of mortality was higher in the telemedicine versus the standard care group (HR, 8.98; 95 percent CI, 6.93 to 10.88; P = 0.0001).

"The findings of no regarding amputation and healing seem promising; however, for telemedical monitoring, a higher mortality throws into question the role of in monitoring ," the authors write.

More information: Abstract
Full Text (subscription or payment may be required)

Journal information: Diabetes Care

Copyright © 2015 HealthDay. All rights reserved.

Citation: Questions raised for telemedical monitoring of diabetic foot ulcers (2015, July 6) retrieved 19 March 2024 from https://medicalxpress.com/news/2015-07-telemedical-diabetic-foot-ulcers.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Aspirin use not found to benefit prostate cancer mortality

7 shares

Feedback to editors